Is the PTV Margin Important for Local Control in Stage I Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Definitive SBRT?

被引：0
|
作者：
Shaverdian, N. [1 ]
Wang, J. [1 ]
Veruttipong, D. [1 ]
Hegde, J. V. [1 ]
Lee, C. [1 ]
Tenn, S. E. [1 ]
Lee, P. [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3097
引用
收藏
页码：E440 / E440
页数：1
相关论文
共 50 条
  • [21] Real-World Data on Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy (SBRT)
    Van der Woude, L.
    Van der Wel, A.
    Van Bockel, L.
    Coremans, I.
    Dekker, A.
    Van Es, C.
    De Jaeger, K.
    Knol, H. P.
    Kolff, W.
    Koppe, F.
    Pomp, J.
    Schinagl, D.
    Spoelstra, F.
    Tissing-Tan, C.
    Ubbels, F.
    Vonk, E.
    Van der Voort-Van Zijp, N.
    Wiegman, E.
    Van der Geest, A.
    Reymen, B.
    Van Kampen, D.
    Damhuis, R.
    Belderbos, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S269 - S270
  • [22] PET-based assessment of local failure patterns in non-small cell lung cancer (NSCLC) treated with definitive radiotherapy
    Sura, S.
    Greco, C.
    Ellen, Y. D.
    Jackson, A.
    Gelblum, D. Y.
    Rosenzweig, K. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S58 - S58
  • [23] The role of tumour volume as a prognostic factor in non-small cell lung cancer (NSCLC) patients treated with definitive radiotherapy
    Joyce, R.
    O'Boyle, G.
    McDermott, R. L.
    Small, C.
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2019, 18 (03) : 218 - 224
  • [24] SBRT for Stage 1 Non-Small Cell Lung Cancer Reply
    Lee, Percy
    Tai, An
    Li, X. Allen
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (04): : 1089 - 1090
  • [25] Definitive Dose Thoracic Radiotherapy In Oligometastatic Stage IV Non-small Cell Lung Cancer (NSCLC)
    Xanthopoulos, E.
    Fernandes, A. T.
    Apisarnthanarax, S.
    Christodouleas, J.
    Eaby-Sandy, B.
    Langer, C. J.
    Evans, T. L.
    Lin, L.
    Hahn, S. M.
    Rengan, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S620 - S620
  • [26] Extent of lymphadenectomy (LA) and outcome for patients with stage I non-small cell lung cancer (NSCLC)
    DeCamp, M. M.
    Recht, A.
    Nikolov, M.
    Flickinger, J. C.
    Varlotto, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients
    L. Ceniceros
    J. Aristu
    E. Castañón
    C. Rolfo
    J. Legaspi
    A. Olarte
    G. Valtueña
    M. Moreno
    I. Gil-Bazo
    Clinical and Translational Oncology, 2016, 18 : 259 - 268
  • [28] Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients
    Ceniceros, L.
    Aristu, J.
    Castanon, E.
    Rolfo, C.
    Legaspi, J.
    Olarte, A.
    Valtuena, G.
    Moreno, M.
    Gil-Bazo, I.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (03): : 259 - 268
  • [29] Radiation therapy of stage I and II non-small cell lung cancer (NSCLC)
    Zierhut, D
    Bettscheider, C
    Schubert, K
    van Kampen, M
    Wannenmacher, M
    LUNG CANCER, 2001, 34 : S39 - S43
  • [30] Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC)
    von Reibnitz, Donata
    Shaikh, Fauzia
    Wu, Abraham J.
    Treharne, Gregory C.
    Dick-Godfrey, Rosalind
    Foster, Amanda
    Woo, Kaitlin M.
    Shi, Weiji
    Zhang, Zhigang
    Din, Shaun U.
    Gelblum, Daphna Y.
    Yorke, Ellen D.
    Rosenzweig, Kenneth E.
    Rimner, Andreas
    ACTA ONCOLOGICA, 2018, 57 (11) : 1567 - 1573
12345